In this respect diagnostic assays should be able to discriminate between the type of IDH-mutation present; non-R132H IDH1/2-mutations comprise ~ 10% of all IDH-mutations in astrocytomas. The gene discussed is IDH2; the disease is astrocytoma (excluding glioblastoma).